Company: APM
Filing Date: 2025-10-06
Form Type: S-4
Source: 0001213900-25-096656
Chunk: 369

Company: Aptorum Group Ltd
Filing Date: 2025-10-06
Form: S-4
Chunk 369
---
3017 – 3041 (2018) 6.Circulating brain -enrichedmicroRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases .Kira S. Sheinerman, Jon B. Toledo, Vladimir G. Tsivinsky, David Irwin, Murray Grossman, Daniel Weintraub, Howard I. Hurtig, Alice Chen -Plotkin, David A. Wolk, Leo F. McCluskey, Lauren B. Elman, John Q. Trojanowski and Samuil R. Umansky. Alzheimer’s Research & Therapy, 9:89 (2017) 7.Universal screening test based on analysis of circulating organ -enrichedmicroRNAs: a novel approach to diagnostic screening .Kira S. Sheinerman and Samuil Umansky. Expert Review of Molecular Diagnostics, 3:329 (2015) 8.Analysis of organ -enrichedmicroRNAs in plasma as an approach to development of Universal Screening Test: feasibility study .Kira S. Sheinerman, Vladimir G. Tsivinsky and Samuil R. Umansky. Journal of Translational Medicine, 11:304 (2013) 211 9.Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study .Kira S. Sheinerman, Vladimir G. Tsivinsky, Laila Abdullah, Fiona Crawford and Samuil R. Umansky. Aging, 5: 925 -938(2013) 10.Circulating cell -freemicroRNA as biomarkers for screening, diagnosis, and monitoring of neurodegenerative diseases and other neurologic pathologies. Kira S. Sheinerman and Samuil R. Umansky. Frontiers in Cellular Neuroscience, 7: 00150 (2013) 11.Early detection of neurodegenerative diseases: Circulating brain -enrichedmicroRNA. Kira S. Sheinerman and Samuil R. Umansky (Editorial). Cell Cycle, 12: 1 -2(2013) 12.Plasma microRNA biomarkers for detection of mild cognitive impairment. Kira S. Sheinerman, Vladimir G. Tsivinsky, Fiona Crawford, Michael J. Mullan, Laila Abdullah, and Samuil R. Umansky. Aging, 4: 590 -607(2012) DiamiR’s